David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
CALL
Oxford Industries
OXM
$549M
| $1.88M | ﹤0.01% |
+22,600
| New | +$1.82M |
|
2227
Fulton Financial
FULT
$4.52B
| $1.87M | ﹤0.01% |
+113,422
| New | +$1.97M |
|
2228
PUT
NCR Voyix
VYX
$1.12B
| $1.87M | ﹤0.01% |
101,712
+76,610
| +305% | +$1.45M |
|
2229
Cooper-Standard Automotive
CPS
$474M
| $1.86M | ﹤0.01% |
14,264
-1,774
| -11% | -$230K |
|
2230
PUT
Lear
LEA
$8.23B
| $1.86M | ﹤0.01% |
10,000
-10,000
| -50% | -$1.96M |
|
2231
Solid Biosciences
SLDB
$1.06B
| $1.85M | ﹤0.01% |
3,470
+1,867
| +116% | +$574K |
|
|
SBNY
2232
CALL
DELISTED
Signature Bank
SBNY
| $1.85M | ﹤0.01% |
+14,500
| New | +$1.9M |
|
2233
CALL
POSCO
PKX
$18B
| $1.85M | ﹤0.01% |
25,000
| – | – |
|
2234
PUT
Old Dominion Freight Line
ODFL
$41.1B
| $1.85M | ﹤0.01% |
37,200
-47,700
| -56% | -$2.37M |
|
2235
Tactile Systems Technology
TCMD
$534M
| $1.85M | ﹤0.01% |
+35,492
| New | +$1.54M |
|
2236
CALL
Inogen
INGN
$147M
| $1.84M | ﹤0.01% |
+9,900
| New | +$1.65M |
|
2237
Center Bancorp
CNOB
$1.61B
| $1.84M | ﹤0.01% |
74,003
+51,553
| +230% | +$1.4M |
|
2238
PJT Partners
PJT
$4.46B
| $1.84M | ﹤0.01% |
34,505
+2,830
| +9% | +$155K |
|
|
MGLN
2239
PUT
DELISTED
Magellan Health Services, Inc.
MGLN
| $1.84M | ﹤0.01% |
19,200
-15,000
| -44% | -$1.44M |
|
2240
Sun Life Financial
SLF
$44.5B
| $1.84M | ﹤0.01% |
45,751
+17,688
| +63% | +$732K |
|
|
TBRG
2241
DELISTED
TruBridge
TBRG
| $1.84M | ﹤0.01% |
55,796
+16,963
| +44% | +$533K |
|
|
GWPH
2242
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.84M | ﹤0.01% |
+13,159
| New | +$1.87M |
|
|
BMTC
2243
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.83M | ﹤0.01% |
39,560
+7,025
| +22% | +$324K |
|
|
FCB
2244
DELISTED
FCB Financial Holdings, Inc.
FCB
| $1.83M | ﹤0.01% |
31,142
+8,955
| +40% | +$526K |
|
2245
PUT
Verisk Analytics
VRSK
$24.5B
| $1.83M | ﹤0.01% |
+17,000
| New | +$1.81M |
|
|
CSFL
2246
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $1.83M | ﹤0.01% |
61,368
+27,394
| +81% | +$814K |
|
2247
Rigel Pharmaceuticals
RIGL
$873M
| $1.82M | ﹤0.01% |
64,396
-17,808
| -22% | -$634K |
|
2248
CALL
PTC Therapeutics
PTCT
$6.13B
| $1.82M | ﹤0.01% |
54,000
-1,800
| -3% | -$56.1K |
|
2249
CALL
PBF Energy
PBF
$7.88B
| $1.82M | ﹤0.01% |
+43,300
| New | +$1.81M |
|
|
PPL
2250
CALL
PPL Corp
PPL
$26.3B
| $1.81M | ﹤0.01% |
63,500
+45,000
| +243% | +$1.25M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.